Alexis N. Lacrue
- Courses5
- Reviews5
- School: University of South Florida
- Campus:
- Department: Public Health
- Email address: Join to see
- Phone: Join to see
-
Location:
4202 E Fowler Ave
Tampa, FL - 33620 - Dates at University of South Florida: November 2014 - December 2017
- Office Hours: Join to see
Biography
Alexis N Lacrue is a/an Instructor in the University Of South Florida department at University Of South Florida
University of South Florida - Public Health
Lead Scientist at The Florida Department of Health
Higher Education
Alexis
LaCrue
Tampa/St. Petersburg, Florida Area
I graduated with dual Bachelor’s degrees in Animal Science and Biology with a minor in Human Biology from New Mexico State University (2000). I later received my Master’s of Science in Veterinary Biomedical Science (2003) and a Ph.D. in Veterinary Pathobiology (2007) from the University of Missouri-Columbia. After graduating with my Ph.D. I moved to Florida for a post-doctoral position, during which time I conducted malaria drug discovery studies.
Currently, I am the Lead Scientist for Arbovirus Serology and Surveillance at the Bureau of Public Health Labs Tampa, as well as an adjunct instructor at the University of South Florida and Hillsborough County Community College. My skills include various molecular biology techniques, cell culture (parasite, bacterial), manipulation of rodent and avian model systems, drug discovery, serological testing (i.e. ELISA, plaque reduction neutralization assays), and scientific writing just to name a few. I really enjoy research, teaching, and working in a collaborative environment and excel at leading a team of individuals to meet organizational goals.
Experience
Unversity of Missouri-Columbia
Doctoral Fellow
Duties: To characterize novel malaria sporozoite genes that could potentially be vaccine candidates.
Skills/expertise: Mosquito infections and dissections, in vivo avian models, cell culture (bacteria and parasite), and molecular techniques (ie. PCR, RT-PCR, gel electrophoresis, fluorescent microscopy, Western blot analysis, SDS-PAGE).Florida Department of Health
Medical Laboratory Scientist
Alexis worked at Florida Department of Health as a Medical Laboratory Scientist
Hillsborough Community College
Adjunct instructor
I teach microbiology, biology, and nutrition and drugs.
University of South Florida
Adjunct Instructor, College of Public Health
I currently teach Public Health Biology (undergraduate) and Emerging Infectious Diseases (graduate) in the College of Public Health. I have also taught Parasitology.
University of South Florida
Research Associate
Duties: Oversea the drug discovery experiments for the Medicines for Malaria Venture (MMV) Grant. My duties were similar to a research and development manager. Design experiments to test novel anti-malarial compounds for efficacy in vitro and in vivo against malaria parasites. Develop experimental protocols. Supervise technical staff and graduate students. Collaborate with colleagues both nationally and internationally. Write grants and manuscripts. Present data to the department and at international meetings.
Skills/expertise: Writing manuscripts and grants. Handling in vivo rodent models, cell culture (bacteria and parasite), and molecular biology techniques (ie. PCR, RT-PCR, qPCR, gel electrophoresis, fluorescence microscopy, light microscopy).Florida Department of Health, Bureau of Public Health Labs
Lead Scientist
Alexis worked at Florida Department of Health, Bureau of Public Health Labs as a Lead Scientist
Education
University of Missouri-Columbia
Doctor of Philosophy (Ph.D.)
Veterinary Pathobiology/Parasitology
University of Missouri-Columbia
Master of Science (MS)
Veterinary Biomedical Science
Unversity of Missouri-Columbia
Doctoral Fellow
Duties: To characterize novel malaria sporozoite genes that could potentially be vaccine candidates. Skills/expertise: Mosquito infections and dissections, in vivo avian models, cell culture (bacteria and parasite), and molecular techniques (ie. PCR, RT-PCR, gel electrophoresis, fluorescent microscopy, Western blot analysis, SDS-PAGE).New Mexico State University
Bachelor's of Science
Animal Sciences
Publications
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
Expression profile of the plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.
Malaria Journal
Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium falciparum PF3D7_1363700.
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
Expression profile of the plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.
Malaria Journal
Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium falciparum PF3D7_1363700.
Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
Malaria Journal
Plasmodium falciparum malaria is a significant problem around the world today, thus there is still a need for new control methods to be developed. Because the sporozoite displays dual infectivity for both the mosquito salivary glands and vertebrate host tissue, it is a good target for vaccine development.
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
Expression profile of the plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.
Malaria Journal
Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium falciparum PF3D7_1363700.
Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
Malaria Journal
Plasmodium falciparum malaria is a significant problem around the world today, thus there is still a need for new control methods to be developed. Because the sporozoite displays dual infectivity for both the mosquito salivary glands and vertebrate host tissue, it is a good target for vaccine development.
The novel Plasmodium gallinaceum sporozoite protein, Pg93, is preferentially expressed in the nucleus of oocyst sporozoites.
Am J Trop Med Hyg
To study gene expression differences between oocyst and salivary gland sporozoites, cDNA libraries previously constructed from the two sporozoite populations of the avian malaria parasite, Plasmodium gallinaceum, were used in a subtractive hybridization protocol to isolate Pg93, a novel oocyst sporozoite gene. Pg93 encodes a putative approximately 76 kDa translated protein that was predicted to localize to the nucleus. Transcriptional analysis indicates that Pg93 is preferentially expressed in oocyst sporozoites versus salivary gland sporozoites. Immunolocalization assays confirm both the nuclear prediction and transcriptional analysis, suggesting that Pg93 is a nuclear protein. BLAST sequence analysis indicates that Pg93 represents a novel gene that has significant homology with a Plasmodium falciparum hypothetical protein and translated Plasmodium knowlesi and Plasmodium vivax nucleotide sequences. This is the first characterization of a Plasmodium nuclear protein that shows preferential expression in one sporozoite population as compared with the other population.
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
Expression profile of the plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.
Malaria Journal
Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium falciparum PF3D7_1363700.
Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
Malaria Journal
Plasmodium falciparum malaria is a significant problem around the world today, thus there is still a need for new control methods to be developed. Because the sporozoite displays dual infectivity for both the mosquito salivary glands and vertebrate host tissue, it is a good target for vaccine development.
The novel Plasmodium gallinaceum sporozoite protein, Pg93, is preferentially expressed in the nucleus of oocyst sporozoites.
Am J Trop Med Hyg
To study gene expression differences between oocyst and salivary gland sporozoites, cDNA libraries previously constructed from the two sporozoite populations of the avian malaria parasite, Plasmodium gallinaceum, were used in a subtractive hybridization protocol to isolate Pg93, a novel oocyst sporozoite gene. Pg93 encodes a putative approximately 76 kDa translated protein that was predicted to localize to the nucleus. Transcriptional analysis indicates that Pg93 is preferentially expressed in oocyst sporozoites versus salivary gland sporozoites. Immunolocalization assays confirm both the nuclear prediction and transcriptional analysis, suggesting that Pg93 is a nuclear protein. BLAST sequence analysis indicates that Pg93 represents a novel gene that has significant homology with a Plasmodium falciparum hypothetical protein and translated Plasmodium knowlesi and Plasmodium vivax nucleotide sequences. This is the first characterization of a Plasmodium nuclear protein that shows preferential expression in one sporozoite population as compared with the other population.
Quinolone-3-diarylethers: a new class of antimalarial drug.
Science Translational Medicine
The goal for developing new antimalarial drugs is to find a molecule that can target multiple stages of the parasite's life cycle, thus impacting prevention, treatment, and transmission of the disease. The 4(1H)-quinolone-3-diarylethers are selective potent inhibitors of the parasite's mitochondrial cytochrome bc1 complex. These compounds are highly active against the human malaria parasites Plasmodium falciparum and Plasmodium vivax. They target both the liver and blood stages of the parasite as well as the forms that are crucial for disease transmission, that is, the gametocytes, the zygote, the ookinete, and the oocyst. Selected as a preclinical candidate, ELQ-300 has good oral bioavailability at efficacious doses in mice, is metabolically stable, and is highly active in blocking transmission in rodent models of malaria. Given its predicted low dose in patients and its predicted long half-life, ELQ-300 has potential as a new drug for the treatment, prevention, and, ultimately, eradication of human malaria.
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
Expression profile of the plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.
Malaria Journal
Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium falciparum PF3D7_1363700.
Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
Malaria Journal
Plasmodium falciparum malaria is a significant problem around the world today, thus there is still a need for new control methods to be developed. Because the sporozoite displays dual infectivity for both the mosquito salivary glands and vertebrate host tissue, it is a good target for vaccine development.
The novel Plasmodium gallinaceum sporozoite protein, Pg93, is preferentially expressed in the nucleus of oocyst sporozoites.
Am J Trop Med Hyg
To study gene expression differences between oocyst and salivary gland sporozoites, cDNA libraries previously constructed from the two sporozoite populations of the avian malaria parasite, Plasmodium gallinaceum, were used in a subtractive hybridization protocol to isolate Pg93, a novel oocyst sporozoite gene. Pg93 encodes a putative approximately 76 kDa translated protein that was predicted to localize to the nucleus. Transcriptional analysis indicates that Pg93 is preferentially expressed in oocyst sporozoites versus salivary gland sporozoites. Immunolocalization assays confirm both the nuclear prediction and transcriptional analysis, suggesting that Pg93 is a nuclear protein. BLAST sequence analysis indicates that Pg93 represents a novel gene that has significant homology with a Plasmodium falciparum hypothetical protein and translated Plasmodium knowlesi and Plasmodium vivax nucleotide sequences. This is the first characterization of a Plasmodium nuclear protein that shows preferential expression in one sporozoite population as compared with the other population.
Quinolone-3-diarylethers: a new class of antimalarial drug.
Science Translational Medicine
The goal for developing new antimalarial drugs is to find a molecule that can target multiple stages of the parasite's life cycle, thus impacting prevention, treatment, and transmission of the disease. The 4(1H)-quinolone-3-diarylethers are selective potent inhibitors of the parasite's mitochondrial cytochrome bc1 complex. These compounds are highly active against the human malaria parasites Plasmodium falciparum and Plasmodium vivax. They target both the liver and blood stages of the parasite as well as the forms that are crucial for disease transmission, that is, the gametocytes, the zygote, the ookinete, and the oocyst. Selected as a preclinical candidate, ELQ-300 has good oral bioavailability at efficacious doses in mice, is metabolically stable, and is highly active in blocking transmission in rodent models of malaria. Given its predicted low dose in patients and its predicted long half-life, ELQ-300 has potential as a new drug for the treatment, prevention, and, ultimately, eradication of human malaria.
A ubiquitous Plasmodium protein displays a unique surface labeling pattern in sporozoites
Molecular and Biochemical Parasitology
The Plasmodium sporozoite is infective for mosquito salivary glands and vertebrate host tissues. Although it is a key developmental stage of the malaria parasite, relatively few sporozoite surface or secreted proteins have been identified and characterized. Herein, we describe the molecular and cellular characterization of a novel surface molecule that is preferentially-expressed in salivary gland sporozoites as compared to oocyst and hemolymph sporozoites. This molecule, designated the sporozoite and erythrocytic stages (SES) protein (formerly known as Pg4), exhibits a spiral surface labeling pattern that spans over a known sporozoite surface antigen, the circumsporozoite protein, with only minor co-localization. SES consists of 551 amino acids encoding a putative 63.2kDa protein that has been shown to be expressed not only on particular sporozoite stages, but also during the asexual and gametocyte stages. This novel protein also has three domains of unknown function that are conserved in at least eight Plasmodium spp. that represent human, avian, non-human primate, and rodent malarias.
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
Expression profile of the plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.
Malaria Journal
Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium falciparum PF3D7_1363700.
Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
Malaria Journal
Plasmodium falciparum malaria is a significant problem around the world today, thus there is still a need for new control methods to be developed. Because the sporozoite displays dual infectivity for both the mosquito salivary glands and vertebrate host tissue, it is a good target for vaccine development.
The novel Plasmodium gallinaceum sporozoite protein, Pg93, is preferentially expressed in the nucleus of oocyst sporozoites.
Am J Trop Med Hyg
To study gene expression differences between oocyst and salivary gland sporozoites, cDNA libraries previously constructed from the two sporozoite populations of the avian malaria parasite, Plasmodium gallinaceum, were used in a subtractive hybridization protocol to isolate Pg93, a novel oocyst sporozoite gene. Pg93 encodes a putative approximately 76 kDa translated protein that was predicted to localize to the nucleus. Transcriptional analysis indicates that Pg93 is preferentially expressed in oocyst sporozoites versus salivary gland sporozoites. Immunolocalization assays confirm both the nuclear prediction and transcriptional analysis, suggesting that Pg93 is a nuclear protein. BLAST sequence analysis indicates that Pg93 represents a novel gene that has significant homology with a Plasmodium falciparum hypothetical protein and translated Plasmodium knowlesi and Plasmodium vivax nucleotide sequences. This is the first characterization of a Plasmodium nuclear protein that shows preferential expression in one sporozoite population as compared with the other population.
Quinolone-3-diarylethers: a new class of antimalarial drug.
Science Translational Medicine
The goal for developing new antimalarial drugs is to find a molecule that can target multiple stages of the parasite's life cycle, thus impacting prevention, treatment, and transmission of the disease. The 4(1H)-quinolone-3-diarylethers are selective potent inhibitors of the parasite's mitochondrial cytochrome bc1 complex. These compounds are highly active against the human malaria parasites Plasmodium falciparum and Plasmodium vivax. They target both the liver and blood stages of the parasite as well as the forms that are crucial for disease transmission, that is, the gametocytes, the zygote, the ookinete, and the oocyst. Selected as a preclinical candidate, ELQ-300 has good oral bioavailability at efficacious doses in mice, is metabolically stable, and is highly active in blocking transmission in rodent models of malaria. Given its predicted low dose in patients and its predicted long half-life, ELQ-300 has potential as a new drug for the treatment, prevention, and, ultimately, eradication of human malaria.
A ubiquitous Plasmodium protein displays a unique surface labeling pattern in sporozoites
Molecular and Biochemical Parasitology
The Plasmodium sporozoite is infective for mosquito salivary glands and vertebrate host tissues. Although it is a key developmental stage of the malaria parasite, relatively few sporozoite surface or secreted proteins have been identified and characterized. Herein, we describe the molecular and cellular characterization of a novel surface molecule that is preferentially-expressed in salivary gland sporozoites as compared to oocyst and hemolymph sporozoites. This molecule, designated the sporozoite and erythrocytic stages (SES) protein (formerly known as Pg4), exhibits a spiral surface labeling pattern that spans over a known sporozoite surface antigen, the circumsporozoite protein, with only minor co-localization. SES consists of 551 amino acids encoding a putative 63.2kDa protein that has been shown to be expressed not only on particular sporozoite stages, but also during the asexual and gametocyte stages. This novel protein also has three domains of unknown function that are conserved in at least eight Plasmodium spp. that represent human, avian, non-human primate, and rodent malarias.
PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
American Journal of Tropical Medicine and Hygiene
Because malaria is still a significant problem worldwide, additional control methods need to be developed. The Plasmodium sporozoite is a good target for control measures because it displays dual infectivity for both mosquito and vertebrate host tissues. The Plasmodium falciparum gene, PFE0565w, was chosen as a candidate for study based on data from PlasmoDB, the Plasmodium database, indicating that it is expressed both at the transcriptional and protein levels in sporozoites, likely encodes a putative surface protein, and may have a potential role in the invasion of host tissues. Additional sequence analysis shows that the PFE0565w protein has orthologs in other Plasmodium species, but none outside of the genus Plasmodium. PFE0565w expresses transcript during both the sporozoite and erythrocytic stages of the parasite life cycle, where an alternative transcript was discovered during the erythrocytic stages. Data show that transcript is not present during axenic exoerythrocytic stages. Despite transcript being present in several life cycle stages, the PFE0565w protein is present only during the salivary gland sporozoite stage. Because the PFE0565w protein is present in salivary gland sporozoites, it could be a novel candidate for a pre-erythrocytic stage vaccine.
Expression profile of the plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.
Malaria Journal
Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium falciparum PF3D7_1363700.
Transcript and protein expression profile of PF11_0394, a Plasmodium falciparum protein expressed in salivary gland sporozoites.
Malaria Journal
Plasmodium falciparum malaria is a significant problem around the world today, thus there is still a need for new control methods to be developed. Because the sporozoite displays dual infectivity for both the mosquito salivary glands and vertebrate host tissue, it is a good target for vaccine development.
The novel Plasmodium gallinaceum sporozoite protein, Pg93, is preferentially expressed in the nucleus of oocyst sporozoites.
Am J Trop Med Hyg
To study gene expression differences between oocyst and salivary gland sporozoites, cDNA libraries previously constructed from the two sporozoite populations of the avian malaria parasite, Plasmodium gallinaceum, were used in a subtractive hybridization protocol to isolate Pg93, a novel oocyst sporozoite gene. Pg93 encodes a putative approximately 76 kDa translated protein that was predicted to localize to the nucleus. Transcriptional analysis indicates that Pg93 is preferentially expressed in oocyst sporozoites versus salivary gland sporozoites. Immunolocalization assays confirm both the nuclear prediction and transcriptional analysis, suggesting that Pg93 is a nuclear protein. BLAST sequence analysis indicates that Pg93 represents a novel gene that has significant homology with a Plasmodium falciparum hypothetical protein and translated Plasmodium knowlesi and Plasmodium vivax nucleotide sequences. This is the first characterization of a Plasmodium nuclear protein that shows preferential expression in one sporozoite population as compared with the other population.
Quinolone-3-diarylethers: a new class of antimalarial drug.
Science Translational Medicine
The goal for developing new antimalarial drugs is to find a molecule that can target multiple stages of the parasite's life cycle, thus impacting prevention, treatment, and transmission of the disease. The 4(1H)-quinolone-3-diarylethers are selective potent inhibitors of the parasite's mitochondrial cytochrome bc1 complex. These compounds are highly active against the human malaria parasites Plasmodium falciparum and Plasmodium vivax. They target both the liver and blood stages of the parasite as well as the forms that are crucial for disease transmission, that is, the gametocytes, the zygote, the ookinete, and the oocyst. Selected as a preclinical candidate, ELQ-300 has good oral bioavailability at efficacious doses in mice, is metabolically stable, and is highly active in blocking transmission in rodent models of malaria. Given its predicted low dose in patients and its predicted long half-life, ELQ-300 has potential as a new drug for the treatment, prevention, and, ultimately, eradication of human malaria.
A ubiquitous Plasmodium protein displays a unique surface labeling pattern in sporozoites
Molecular and Biochemical Parasitology
The Plasmodium sporozoite is infective for mosquito salivary glands and vertebrate host tissues. Although it is a key developmental stage of the malaria parasite, relatively few sporozoite surface or secreted proteins have been identified and characterized. Herein, we describe the molecular and cellular characterization of a novel surface molecule that is preferentially-expressed in salivary gland sporozoites as compared to oocyst and hemolymph sporozoites. This molecule, designated the sporozoite and erythrocytic stages (SES) protein (formerly known as Pg4), exhibits a spiral surface labeling pattern that spans over a known sporozoite surface antigen, the circumsporozoite protein, with only minor co-localization. SES consists of 551 amino acids encoding a putative 63.2kDa protein that has been shown to be expressed not only on particular sporozoite stages, but also during the asexual and gametocyte stages. This novel protein also has three domains of unknown function that are conserved in at least eight Plasmodium spp. that represent human, avian, non-human primate, and rodent malarias.
Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei.
PLoS One
Artemisinin (ART) is the recommended first line therapy for treating uncomplicated and drug-resistant Plasmodium falciparum, the most pathogenic form of malaria. However, treatment failure following ART monotherapy is not uncommon and resistance to this rapidly acting drug has been reported in the Thai-Cambodian border. Recent in vitro studies have shown that following treatment with dihydroartemisinin (DHA), the development of ring-stage parasites is arrested for up to 20 days. These arrested (i.e. dormant) rings could be responsible for the recrudescence of infection that is observed following ART monotherapy. To develop a better understanding of the stage-specific effects of ART and determine if dormancy occurs in vivo, the ART derivative artesunate (AS) was used to treat mice infected with the synchronous rodent malaria parasites P. vinckei petteri (non-lethal) and P. v. vinckei (lethal). Results show that in both the non-lethal and lethal strains, ring-stage parasites are the least susceptible to treatment with AS and that the day of treatment has more of an impact on recrudescence than the total dose administered. Additionally, 24 hrs post-treatment with AS, dormant forms similar in morphology to those seen in vitro were observed. Finally, rate of recrudescence studies suggest that there is a positive correlation between the number of dormant parasites present and when recrudescence occurs in the vertebrate host. Collectively, these data suggest that dormancy occurs in vivo and contributes to recrudescence that is observed following AS treatment. It is possible that this may represent a novel mechanism of parasite survival following treatment with AS.
Positions
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Microbiology
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
Florida Public Health Association
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
American Society for Tropical Medicine and Hygiene
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
United Faculty of Florida
Member
urn:li:fs_position:(ACoAAAVyPhoBQBAV4TzsdvP02MbH9_7VL4YQrzk,381355071)
